Pluszero
5132
Metaplanet
3350
Waqoo
4937
Gumi
3903
Chiome Bioscience
4583
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -8.98%3.04B | -3.44%730.08M | -9.68%768.62M | 4.30%808.5M | -23.42%737.09M | 0.01%3.34B | -23.18%756.06M | 6.95%851.01M | 1.38%775.17M | 20.32%962.51M |
Cost of revenue | -11.54%2.13B | -6.70%509.84M | -13.73%523.04M | 5.04%582.34M | -26.52%515.09M | -0.66%2.41B | -26.84%546.48M | 8.36%606.26M | 3.38%554.38M | 20.58%700.99M |
Gross profit | -2.42%913.98M | 5.09%220.25M | 0.34%245.58M | 2.43%226.15M | -15.11%222M | 1.77%936.64M | -11.63%209.58M | 3.62%244.76M | -3.32%220.78M | 19.62%261.52M |
Operating expense | 0.85%861.46M | -2.80%214.91M | 4.03%217.8M | -1.08%212.52M | 3.50%216.22M | 2.10%854.22M | 7.03%221.11M | 1.09%209.37M | 0.29%214.83M | 0.07%208.91M |
Staff costs | -3.39%425.4M | ---- | ---- | ---- | ---- | -1.79%440.34M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | 3.45%231.08M | ---- | ---- | ---- | ---- | 3.79%223.37M | ---- | ---- | ---- | ---- |
-Selling and marketing expense | 5.77%112.08M | ---- | ---- | ---- | ---- | 7.63%105.96M | ---- | ---- | ---- | ---- |
-General and administrative expense | 1.36%119.01M | ---- | ---- | ---- | ---- | 0.55%117.41M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 40.25%12.31M | ---- | ---- | ---- | ---- | -5.66%8.78M | ---- | ---- | ---- | ---- |
-Depreciation | 40.25%12.31M | ---- | ---- | ---- | ---- | -5.66%8.78M | ---- | ---- | ---- | ---- |
Rent and land expenses | 2.92%140.97M | ---- | ---- | ---- | ---- | 15.20%136.98M | ---- | ---- | ---- | ---- |
Other operating expenses | 15.51%51.7M | ---- | ---- | ---- | ---- | -0.23%44.75M | ---- | ---- | ---- | ---- |
Operating profit | -36.28%52.52M | 146.34%5.34M | -21.51%27.78M | 129.08%13.63M | -89.02%5.78M | -1.54%82.42M | -137.67%-11.52M | 21.60%35.39M | -57.95%5.95M | 432.99%52.61M |
Net non-operating interest income (expenses) | -135.91%-11.01M | -213.78%-3.89M | -199.76%-3.75M | -66.27%-2.09M | -38.93%-1.27M | -104.52%-4.67M | -21.79%-1.24M | -27.68%-1.25M | -330.48%-1.26M | -10,288.89%-917K |
Non-operating interest income | -31.25%33K | -40.00%3K | 15.00%23K | -20.00%4K | -83.33%3K | 0.00%48K | 0.00%5K | 5.26%20K | 0.00%5K | -5.26%18K |
Non-operating interest expense | 134.20%11.04M | 212.76%3.9M | 196.85%3.77M | 65.93%2.09M | 36.58%1.28M | 102.36%4.71M | 21.68%1.25M | 27.25%1.27M | 324.92%1.26M | 9,250.00%935K |
Net investment income | -2.89%537K | 0 | 0.25%404K | 0 | -11.33%133K | 2.98%553K | 0 | -0.25%403K | 0 | 150K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 96.08%-131K | 93.82%-131K | 0 | 84.15%-3.34M | 92.28%-2.12M | -139.87%-187K | -1.12M | -98.49%90K | ||
Less:Other special charges | -89.24%131K | ---- | ---- | ---- | ---- | 359.49%1.22M | --0 | --187K | --1.12M | ---90K |
Less:Write off | --0 | ---- | ---- | ---- | ---- | -90.15%2.12M | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -166.42%-1.7M | -345.71%-172K | -187.59%-1.84M | -4.47%342K | -203.45%-30K | 1,049.55%2.55M | 193.33%70K | 1,010.87%2.1M | -4.79%358K | -80.79%29K |
Income before tax | -48.12%40.22M | 107.64%1.13M | -38.00%22.6M | 202.21%11.88M | -91.14%4.6M | 26.84%77.52M | -839.67%-14.82M | 26.71%36.45M | -72.64%3.93M | 225.21%51.96M |
Income tax | -19.16%17.53M | 126.66%4.26M | -55.60%7.12M | -48.66%3.65M | -82.76%2.5M | 368.72%21.68M | 42.40%-15.97M | 21.44%16.04M | -26.68%7.11M | 53.44%14.51M |
Net income | -59.36%22.69M | -371.50%-3.13M | -24.16%15.48M | 359.50%8.23M | -94.39%2.1M | -1.16%55.84M | -96.13%1.15M | 31.18%20.41M | -167.81%-3.17M | 474.36%37.45M |
Net income continuous operations | -59.36%22.69M | -371.74%-3.13M | -24.16%15.48M | 359.53%8.24M | -94.39%2.1M | -1.16%55.84M | -96.13%1.15M | 31.19%20.41M | -167.81%-3.17M | 474.36%37.45M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -59.36%22.69M | -371.50%-3.13M | -24.16%15.48M | 359.50%8.23M | -94.39%2.1M | -1.16%55.84M | -96.13%1.15M | 31.18%20.41M | -167.81%-3.17M | 474.36%37.45M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -59.36%22.69M | -371.50%-3.13M | -24.16%15.48M | 359.50%8.23M | -94.39%2.1M | -1.16%55.84M | -96.13%1.15M | 31.18%20.41M | -167.81%-3.17M | 474.36%37.45M |
Gross dividend payment | ||||||||||
Basic earnings per share | -59.33%6.3 | -368.75%-0.86 | -24.20%4.29 | 360.23%2.29 | -94.42%0.58 | -1.15%15.49 | -96.12%0.32 | 31.32%5.66 | -167.69%-0.88 | 474.03%10.39 |
Diluted earnings per share | -59.33%6.3 | -371.50%-0.8671 | -24.20%4.29 | 359.50%2.2847 | -94.42%0.58 | -1.15%15.49 | -96.13%0.3194 | 31.32%5.66 | -175.45%-0.8804 | 474.03%10.39 |
Dividend per share | 0.00%2 | 0.00%2 | 0 | 0 | 0 | 0.00%2 | 0.00%2 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |